Optimizing Hepatitis C Therapy in HIV/hepatitis C Virus (HCV) Coinfected Patients: Analysis of HCV Viral Kinetics on Treatment

Paul Damien James; David KH Wong

doi:10.1155/2012/384630

Canadian Journal of Infectious Diseases and Medical Microbiology (Jan 2012)

Optimizing Hepatitis C Therapy in HIV/hepatitis C Virus (HCV) Coinfected Patients: Analysis of HCV Viral Kinetics on Treatment

Paul Damien James,
David KH Wong

Affiliations

Paul Damien James: Department of Internal Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
David KH Wong: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

DOI: https://doi.org/10.1155/2012/384630
Journal volume & issue: Vol. 23, no. 1
pp. 31 – 35

Abstract

Read online

INTRODUCTION: Hepatitis C virus (HCV) infection is potentially curable, but the sustained virological response (SVR) has been shown to be lower in patients coinfected HIV. A single-centre experience treating individuals with HCV and HIV coinfection is reported.

Published in Canadian Journal of Infectious Diseases and Medical Microbiology

ISSN: 1712-9532 (Print); 1918-1493 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases; Science: Microbiology
Website: https://onlinelibrary.wiley.com/journal/9575

About the journal